ATLANTA, GA, Jan. 24, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — Avra, Inc. (OTC PINK: AVRN), operating as Springs Rejuvenation, (“Spring”), a Chamblee, Georgia based anti-aging and stem cell center focusing on stem cell therapy, today announced that it has entered a lease for a new clinic location in Ft. Lauderdale, FL. The property is located in a beautiful upscale office park with great access to freeways and airports.
This location will feature the Company’s C-arm, high-definition 3D imaging technology equipment for direct visualization of the injection point, which allow the Company to serve the previously unmet and growing patient pool, of many low back pain sufferers that it has previously been underserved. Avra expects this emerging market to positively impact their revenues in 2022.
The founder of Springs, Dr. Charles A. Pereyra, stated, “After months of negotiation and navigating through licensing requirements with the city of Fort Lauderdale, the lease for our first new clinic of 2022 is finally signed. To shorten the overall timeline to open, we have already ordered all of the furniture and equipment needed to begin operations. We expect to hold a grand opening event in mid-February.
“We are extremely excited about the new Florida location. Our core team members have strong contacts in the south Florida market; through those contacts we have already established some strategic partnerships that should produce patients rapidly. Additionally, our research indicates this area is a hot spot for our treatments.”
About Springs Rejuvenation Inc.
At Springs Rejuvenation we strive to be at the cutting edge of regenerative medicine and anti-aging research. Our mission is to provide patients with individualized, state-of-the-art treatment, returning each patient to their natural mobility as quickly as possible.
With the goal of addressing the root cause of your pain, rather than just masking it, we want to help you achieve whole body health and rejuvenation. This will help you feel stronger, improve mood, look younger, heal faster and perform at the optimal level. Our patients have found both freedom from pain and improved quality of life.
Our professional staff is uniquely composed of physicians/researchers in the Stem Cell, Anti-Aging research and regenerative medicine, also including sports-related injuries and chronic joint pain.
Our Medical Director & Founder is Dr. Charles A. Pereyra is the founder of Springs Rejuvenation Stem Cell Therapy in Atlanta, GA (since 2018). He is our current lead clinical Physician and an expert in Stem Cell, Anti-Aging research and Regenerative medicine. Dr. Juan Pablo Nieto specializes in sports-related injuries as well as chronic joint pain. His has expertise experience with diagnostic ultrasound exams as well as joint and tendon injections with PRP, & prolotherapy. His highlights include caring/treating professional athletes: NBA Wizards & D1 level athletes from different multiple sports and presented research at national conferences.
This press release contains forward-looking statements as defined within Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements relate to future events, including our ability to raise capital, or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.
For a discussion of these risks and uncertainties, please see our filings with the OTC Markets Group Inc. Our public filings with the OTC Markets Group Inc are available from commercial document retrieval services and at the website maintained by the OTC Markets at https://www.otcmarkets.com/stock/AVRN/disclosure
Company Twitter: @SpringsRejuven1
The content is by GlobeNewswire. DKODING Media is not responsible for the content provided or any links related to this content. DKODING Media is not responsible for the correctness, topicality or the quality of the content.